According to Shanwaishan's announcement, Hunan Xiangjiang Health Venture Capital Partnership and Hunan Xiangjiang Liyuan Jiankun Venture Capital Partnership, which hold more than 5% of the company's shares, were reduced by 4.077,700 shares through a major transaction from October 16 to October 21, 2026, accounting for 0.91% of the company's total share capital. After this change in equity, the two held a total of 22.372 million shares of the company, accounting for 4.999999% of the total share capital. This change will not lead to changes in the controlling shareholders and actual controllers of the company, and will not affect the proposed acquisition.

According to Shanwaishan's announcement, Hunan Xiangjiang Health Venture Capital Partnership and Hunan Xiangjiang Liyuan Jiankun Venture Capital Partnership, which hold more than 5% of the company's shares, were reduced by 4.077,700 shares through a major transaction from October 16 to October 21, 2026, accounting for 0.91% of the company's total share capital. After this change in equity, the two held a total of 22.372 million shares of the company, accounting for 4.999999% of the total share capital. This change will not lead to changes in the controlling shareholders and actual controllers of the company, and will not affect the proposed acquisition.